WebNov 24, 2024 · Ms. Rachel Mears serves as Partner at Jeito. She also serves as Board Member at Innoskel, HIBio, Neogene and Quell Therapeutics. Over 18 years of experience … WebRachel Mears Investor - Jeito 6h Report this post Report Report. Back Submit. Exciting day for ...
Jeito Capital co-leads a EUR 104 million financing in Noema …
WebRachel Mears is a partner at Jeito Capital and has over 20 years of transactional, operational, and legal experience in biotechnology and pharma companies. She led … WebSep 20, 2024 · Jeito Capital was founded and directed by Rafaèle Tordjman and was launched in January 2024. ... Other managing partners include Sabine Dandiguian and … piste
20+ "Rachel Mears" profiles LinkedIn
WebNov 29, 2024 · In connection with the financing, Rachel Mears (Partner at Jeito Capital), Jeffrey Long-McGie (Managing Director at Ridgeback Capital) ... Jeito Capital is based in Paris with a presence in Europe and the United States. For more information, please visit www.jeito.life, or follow on Twitter @Jeito_life or LinkedIn. WebJEITO’s investment in Noema Pharma is a perfect illustration of our strategy: investing in differentiating and innovative therapies for which the medical… Rachel Mears auf LinkedIn: #jeitocapital #privateequity #biopharma #neurology #healthcare WebNov 1, 2024 · Rachel Mears, J.D., Partner at Jeito Capital; Mark Murcko, Ph.D., Founding Chief Scientific Officer at Dewpoint Therapeutics and Relay Therapeutics; and; Carol Suh, Partner at ARCH Venture Partners; In addition to HI-Bio's executive team and Board, the company will benefit from the expertise of several accomplished scientific advisors. piste 4x4 haute savoie